Different schemes of B-cell chronic lymp
โ
Oksana M. Polyshchuk; Iryna S. Dyagil; Viktor I. Klymenko; Dimitry A. Bazyka; Ir
๐
Article
๐
2005
๐
Wielkopolskie Centrum Onkologii
๐
Polish
โ 121 KB
## Background Remarkable advance in the knowledge of the biology and treatment of chronic lymphocytic leukaemia (CLL) has been noted in recent years. CLL resembles several heterogeneous diseases with variable morphological features. New agents with antileukemic activity have been introduced recent